Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisions

Name: Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisions
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Anyone can find out if a submission has been accepted for review by Health Canada by searching the submissions under review list. We publish Regulatory Decision Summaries (RDS). These summaries explain the purpose of the submission and the reason(s) for Health Canada’s decision on certain health products seeking market authorization. You can access RDSs through the Drug and Health Product Register.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-12-02

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisions (English, HTML) HTML
Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisions (French, HTML) HTML

Related open data

Health Canada